MediciNova Appoints Dr. Christopher Breder as Clinical and Regulatory Advisor

MediciNova has appointed Dr. Christopher Breder, MD, PhD, as Clinical and Regulatory Advisor. Breder has over 20 years of experience at the FDA and major pharmaceutical companies, and has played a key role in the review and initial approvals of numerous therapies for neurological conditions. He will provide strategic guidance for MediciNova's drug development programs and lead the Scientific Advisory Board upon its formation. Breder's appointment will be invaluable in accelerating MediciNova's mission to deliver transformative therapies to patients.